Close

Drug Research

Oxford researchers launch HIV vaccine trial

The University of Oxford has launched a Phase I trial of a novel mosaic vaccine targeting a ‘broad range’ of HIV variants. The HIV-CORE 0052...

Roche & Mimetas collaborate to develop human disease models for drug development

Roche is teaming up with Mimetas, a provider of organ-on-chip-based disease model to develop human disease models to characterize novel compounds in inflammatory bowel...

BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology

BioMed X, a leading independent research institute, announced the start of its eighth joint research program with Merck KGaA, Darmstadt, Germany. The new program...

Recipharm signs Memorandum of Understanding (MOU) for the fill finish of vaccines and biotherapeutics in Morocco

Global contract development and manufacturing organisation (CDMO), Recipharm, has signed an MOU, along with His Majesty the King of Morocco, Mohammed VI, the Moroccan...

GSK and Alector to develop antibodies for neurodegenerative diseases

GlaxoSmithKline plc and Alector announced a strategic global collaboration for the development and commercialisation of two clinical-stage, potential first-in-class monoclonal antibodies (AL001 and AL101)...

Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19

Cipla Limited, Dr. Reddy’s Laboratories Ltd., Emcure Pharmaceuticals Limited, Sun Pharmaceutical Industries Limited, and Torrent Pharmaceuticals Limited, announced that the five companies will collaborate...

Sanofi launches dedicated vaccines mRNA Center of Excellence

Sanofi will invest approximately €400 million annually in a first-of-its kind vaccines mRNA Center of Excellence. The Center will work to accelerate the development...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read